Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
RESEARCH TOOLSreports
Holding GB:0RG8?
Track your performance easily
0RG8 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€139.45 - €280.80
Previous Close€174.98
Volume4.40K
Average Volume (3M)26.88K
Market Cap
€17.03B
Enterprise Value€18.10B
Total Cash (Recent Filing)€133.00M
Total Debt (Recent Filing)€1.14B
Price to Earnings (P/E)99.3
Beta1.63
Next Earnings
Jan 23, 2025EPS Estimate
€0.97Last Dividend Ex-Date
Apr 02, 2024Dividend Yield0.41%
Share Statistics
EPS (TTM)1.76
Shares OutstandingN/A
10 Day Avg. Volume21,888
30 Day Avg. Volume26,875
Standard Deviation0.12
R-Squared0.00156
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)6.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€216.33Price Target Upside23.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Sartorius Stedim Biotech News
PremiumCompany Announcements
Sartorius Stedim Biotech Reports H1 2024 Results
PremiumCompany Announcements
Sartorius Stedim Biotech Adjusts 2024 Outlook
PremiumCompany Announcements
Sartorius Stedim Biotech Revises 2024 Guidance
PremiumCompany Announcements
Sartorius Biotech’s Latest Share Capital Update
PremiumCompany Announcements
Sartorius Stedim Biotech Shows Solid LiquidityPremiumCompany Announcements
Sartorius Stedim Biotech Shares and Voting Rights UpdateOptions Prices
Currently, No data available
---
Ownership Overview
― Insiders
3.71% Mutual Funds
<0.01% Other Institutional Investors
94.25% Public Companies and
Individual Investors
0RG8 FAQ
What was Sartorius Stedim Biotech’s price range in the past 12 months?
Sartorius Stedim Biotech lowest share price was €139.45 and its highest was €280.80 in the past 12 months.
What is Sartorius Stedim Biotech’s market cap?
Currently, no data Available
When is Sartorius Stedim Biotech’s upcoming earnings report date?
Sartorius Stedim Biotech’s upcoming earnings report date is Jan 23, 2025 which is in 60 days.
How were Sartorius Stedim Biotech’s earnings last quarter?
Sartorius Stedim Biotech released its earnings results on Oct 17, 2024. The company reported €0.76 earnings per share for the quarter, missing the consensus estimate of €0.797 by -€0.037.
Is Sartorius Stedim Biotech overvalued?
According to Wall Street analysts Sartorius Stedim Biotech’s price is currently Undervalued.
Does Sartorius Stedim Biotech pay dividends?
Sartorius Stedim Biotech pays a Annually dividend of €0.69 which represents an annual dividend yield of 0.41%. See more information on Sartorius Stedim Biotech dividends here
What is Sartorius Stedim Biotech’s EPS estimate?
Sartorius Stedim Biotech’s EPS estimate is €0.97.
How many shares outstanding does Sartorius Stedim Biotech have?
Sartorius Stedim Biotech has 97,330,410 shares outstanding.
What happened to Sartorius Stedim Biotech’s price movement after its last earnings report?
Sartorius Stedim Biotech reported an EPS of €0.76 in its last earnings report, missing expectations of €0.797. Following the earnings report the stock price went up 15.929%.
Which hedge fund is a major shareholder of Sartorius Stedim Biotech?
Currently, no hedge funds are holding shares in GB:0RG8
---
Sartorius Stedim Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.69%
12-Months-Change
Fundamentals
Return on Equity
5.20%
Trailing 12-Months
Asset Growth
0.48%
Trailing 12-Months
Company Description
Sartorius Stedim Biotech
Sartorius Stedim Biotech is the leading provider of tools for biopharmaceutical fermentation and fluid management. Parent Sartorius AG has a 74% stake in the company, with 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (40% of 2019 sales), the Americas (35%), and Asia-Pacific (25%). Sartorius Stedim Biotech employs over 6,200 people and has operations in more than 20 countries.
---
0RG8 Stock 12 Month Forecast
Average Price Target
€216.33
▲(23.63% Upside)
Technical Analysis
Best Analysts Covering 0RG8
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-9.55%
downgraded a sell rating 4 months ago
Copying Delphine Le Louet's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -9.55% per trade.
---